BioGend Therapeutics Co., Ltd. (TPEX:6733)
33.75
-0.20 (-0.59%)
Mar 24, 2026, 1:30 PM CST
5.80% (1Y)
| Market Cap | 4.20B +0.7% |
| Revenue (ttm) | 222.34M +32.6% |
| Net Income | -84.61M |
| EPS | -0.69 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 180,781 |
| Average Volume | 238,357 |
| Open | 34.10 |
| Previous Close | 33.95 |
| Day's Range | 33.60 - 34.50 |
| 52-Week Range | 23.20 - 49.15 |
| Beta | 0.19 |
| RSI | 31.33 |
| Earnings Date | Feb 26, 2026 |